Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site

BACKGROUND: Hormone receptor and HER-2/neu discordance between the primary lesion and first metastasis has been reported. This study was performed to determine further biomarker discordance rates between the first and subsequent metastatic breast cancer lesions. METHODS: We performed a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Lower, Elyse E, Khan, Shagufta, Kennedy, Diane, Baughman, Robert P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546587/
https://www.ncbi.nlm.nih.gov/pubmed/28814897
http://dx.doi.org/10.2147/BCTT.S137709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546587/
https://www.ncbi.nlm.nih.gov/pubmed/28814897
http://dx.doi.org/10.2147/BCTT.S137709

Ejemplares similares